Market Research Logo

Britannia Pharmaceuticals Limited - Strategic SWOT Analysis Review

Britannia Pharmaceuticals Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations.

The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Britannia Pharmaceuticals Limited (BPL) is a UK based pharmaceutical company, which specializes in orphan drugs (drugs for rare diseases affecting small patient populations). The company develops and markets products in the area of Parkinson's disease, wound healing and respiratory disorders. It is also focuses on evaluating opportunities for the neurology market and exploring ways to bring new products into the market. Its products include apomorphine hydrochlorode, a dopamine agonist. In addition, the company also developed non-opiate based therapeutics for the treatment of opiate detoxification and withdrawal. BPL is a part of the STADA Arzneimittel AG group of companies.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Britannia Pharmaceuticals Limited - Key Facts
Britannia Pharmaceuticals Limited - Key Employees
Britannia Pharmaceuticals Limited - Major Products and Services
Britannia Pharmaceuticals Limited - History
Britannia Pharmaceuticals Limited - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Britannia Pharmaceuticals Limited - Business Description
Britannia Pharmaceuticals Limited - Corporate Strategy
Britannia Pharmaceuticals Limited - SWOT Analysis
SWOT Analysis - Overview
Britannia Pharmaceuticals Limited - Strengths
Strength - Research and Development
Strength - Niche Offerings
Strength - Support from Parent
Britannia Pharmaceuticals Limited - Weaknesses
Weakness - Reliance on Distributors
Britannia Pharmaceuticals Limited - Opportunities
Opportunity - Lead Product Candidate
Opportunity - Growing Market for Orphan Drugs
Britannia Pharmaceuticals Limited - Threats
Threat - Uncertain R&D Outcomes
Threat - Rapid Technological Change
Threat - Intense Competition
Britannia Pharmaceuticals Limited - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Britannia Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Britannia Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Britannia Pharmaceuticals Limited, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Britannia Pharmaceuticals Limited, Key Facts
Britannia Pharmaceuticals Limited, Key Employees
Britannia Pharmaceuticals Limited, Major Products and Services
Britannia Pharmaceuticals Limited, History
Britannia Pharmaceuticals Limited, Key Competitors
Britannia Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Britannia Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Britannia Pharmaceuticals Limited, Recent Deals Summary
List of Figures
Britannia Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Britannia Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report